NCT01479426

A Trial to Evaluate the Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Sexual Function in Men With Erectile Dysfunction

Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Erectile Dysfunction

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: Male
• Age: 19 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Korea red ginseng has been used in maintaining vitality throughout the globally and metabolism and actions on neurologic, cardiovascular, and endocrinologic system are studied. KRG has been used in various ailment, and to prove its efficacy for erectile dysfunction an international study on contries other than Korean was performed. In the present study, subjects with borderline organic and psychogenic erectile dysfunction will be included. KRG will be give daily, and placebo will be give as control. Outcomes including libido, erection, sexual activity, and sexual satisfaction will be measured.

Detailed description

Among the three main lines of therapy for erectile dysfunction (ED), that is, oral therapy, self-injection therapy and penile prosthesis implantation, the first line therapy is always the first option. Despite the successful advent of sildenafil, the first effective oral agent for ED, further development of new drugs and phytochemical studies of widely known herbal plants are desirable. Furthermore, there seems to be a large population that prefers to use phytotherapies rather than pharmaceutical drugs for their health. Korean red ginseng, a phytotherapy plants, used frequently for ED. Ginseng is one of the most popular herbs in both Eastern and Western countries. It is known as a traditional Asian medicine for stimulation of sexual function and studies have shown the effects of ginseng on relaxation of penile corpus cavernous smooth muscle in many studies. In the present study, the investigators will be determined the real role of Korean red ginseng in the treatment of ED.

Conditions

• Healthy Subjects(Only Men)

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	EFLA400	EFLA400(960mg/day)for 12 weeks
DIETARY_SUPPLEMENT	Placebo	Placebo(960mg/day) for 12 weeks

Timeline

• Start date: 2010-12-01
• Primary completion: 2011-12-01
• Completion: 2012-02-01
• First posted: 2011-11-24
• Last updated: 2019-09-23
• Results posted: 2019-09-23

Locations

1 site across 1 country: South Korea